Spelling suggestions: "subject:"syringomyelie"" "subject:"syringomyelia""
1 |
Characterization of the regulatory mechanism controlling phytotoxin production by Pseudomonas syringae pv. syringaeWang, Nian 25 April 2007 (has links)
Syringopeptin (syp) and syringomycin (syr) are major necrosis-inducing
lipodepsipeptide phytotoxins produced by P. syringae pv. syringae. This report
demonstrates that syringopeptin production is activated by plant signal molecules.
Syringopeptin production by BR132 was increased two-fold by addition of arbutin (100
õM) and D-fructose (0.1%) to syringomycin minimal medium (SRM). Subgenomic
analysis of transcriptional expression with a 70-mer oligonucleotide microarray
demonstrated that the syr-syp genes are induced 2.5- to 10.5-fold by arbutin and
D-fructose. The syr-syp genomic island was found to be organized into 12
transcriptional units based on reverse transcriptional PCR (RT-PCR) and computer
analysis. The transcriptional start sites of the salA gene and operons III and IV were
located 63, 75, and 104-bp upstream of the start codons of salA, syrP, and syrB1,
respectively, using primer extension analysis. The predicted -10/-35 promoter region of
operon IV was confirmed based on mutagenesis analyses of the syrB1::uidA reporter
with ò-glucuronidase (GUS) assays. A 20-bp conserved sequence (TGTCccgN4cggGACA) with dyad symmetry around the -35 region was identified via
computer analysis for the syr-syp genes/operons responsible for biosynthesis and
secretion of syringomycin and syringopeptin. Expression of the syrB1::uidA fusion was
decreased 59% when 6-bp was deleted from the 5â end of the syr-syp box in the
promoter region of operon IV. These results demonstrate that the conserved promoter
sequences of the syr-syp genes contribute to the co-regulation of syringomycin and
syringopeptin production. Microarray analysis established that the syr-syp genes
responsible for synthesis and secretion of syringomycin and syringopeptin belong to the
SyrF regulon. Vector pMEKm12 was successfully used to express both SalA and SyrF
proteins fused to maltose-binding protein (MBP). Both MBP-SalA and MBP-SyrF
fusion proteins were purified with maltose-affinity chromatography. Gel shift analysis
revealed that the purified MBP-SyrF, but not the MBP-SalA fusion protein, bound to a
262-bp fragment containing the syr-syp box. Purified MBP-SalA caused the shift of a
324-bp band containing the putative syrF promoter. Gel filtration analysis or
cross-linking experiments indicated that both SalA and SyrF form dimers in vitro. This
study may provide an important perspective on the regulation of syringomycin and
syringopeptin production.
|
2 |
Scalable Bio-Production of High Value Products in BacteriaKawasaki, Yukie 01 May 2015 (has links)
Biliverdin IXα is a green bile pigment produced by enzymatic cleavage of a tetrapyrrole ring of heme by heme oxygenase. While biliverdin IXα is emerging as an effective cytoprotectant, the conventional method for producing biliverdin IXα by chemical conversion of animal bile is not suitable for large scale production. A novel scalable production method was pursued via bacterial fermentation. Recombinant Escherichia coli strains were obtained by sequence optimization and plasmid transformation of a cyanobacterial heme oxygenase gene. Further strain development was done by plasmid overexpression of a native E. coli flavodoxin gene as a possible electron donor for heterogeneous heme oxygenase. The resulting strains were grown in a fed-batch culture system optimized for biliverdin IXα production.
Syringomycin E is a lipodepsinonapeptide produced by certain strains of Pseudomonas syringae pv. syringae by nonribosomal peptide synthesis. Though syringomycin E had been considered a phytotoxin in the past, recent research results indicate that syringomycin E is a natural fungicide that is not toxic to animals and plants. Syringomycin E is a potential fungicide especially for use in the organic agriculture sector. New strains of P. syringae pv. syringae were isolated through ultraviolet mutagenesis and screenings for enhanced capability to produce syringomycin E especially under agitated conditions. Fermentative production was conducted in a newly formulated medium and the product was purified through a large scale chromatography system using organic-compatible solvents. Purified syringomycin E was tested on cucumber seeds to examine its antifungal activity against a soil-borne pathogen Pythium ultimum. Syringomycin E was able to inhibit Pythium infection and protected seeds and seedlings without developing disease symptoms.
This dissertation research showed scalable production of two natural products, biliverdin IXα and syringomycin E in bacterial platforms. Strain development by gene recombination and mutation was done to obtain bacterial strains capable of overproducing desired metabolites. The resulting strains were grown in fermenters to maximize the yields under agitated conditions. Monitoring growth parameters and medium modifications were critical to achieve large scale production.
|
3 |
Molecular analysis of secretion genes located on the syr-syp genomic island of Pseudomonas syringae pv. syringae strain B301DKang, Hyojeung 17 February 2005 (has links)
An RND (resistance-nodulation-cell division) transporter, called the PseC protein, was identified at the left border of the syr-syp genomic island of Pseudomonas syringae pv. syringae strain B301D. The PseC protein exhibited amino acid homology to a putative RND transporter of Ralstonia solanacearum with identities of 61% (i.e., PseC). The pseC mutant strain showed a larger reduction in syringopeptin secretion (67%) than syringomycin secretion (41%). A β-glucuronidase assay with a pseA::uidA reporter
construct indicated that the GacS/A two-component system controls expression of the pseA gene. Expression of the sypA gene by mutant strain B301D-HK4 corresponded to approximately 13% of that by parental strain B301D, whereas the syrB1 gene expression by mutant strain B301D-HK4 was nearly 61%. Mutant strain B301D-HK4 was reduced in virulence by about 58% as compared to parental strain B301D. A drug-supersensitive acrB mutant of E. coli showed increased resistance to acriflavine and tetracycline upon heterologous expression of the pseA, pseB, and pseC genes. Thus, the PseC protein, an RND transporter, has an important role in secretion of syringomycin and syringopeptin.
An ATP-binding cassette (ABC) transporter, called the PseF protein, was identified at the left border of the syr-syp genomic island. The PseF protein exhibited amino acid homology to a putative ABC transporter of E. coli W3104 with identities of 57.6% (i.e., PseF to MacB). The pseF mutant strain showed significant reduction in secretion of syringomycin (74%) and syringopeptin (71%). Expression of the sypA gene by mutant strain B301D-HK7 was approximately 6.9% as compared to that of parental strain B301D, while the syrB1 gene expression by mutant strain B301D-HK7 was nearly 14.6%. Mutant strain B301D-HK7 was less virulent by approximately 67% than parental strain B301D. Expression of the pseF gene was induced approximately six times by strain B301D grown on SRMAF, as compared to that of strain B301D grown on SRM. During infection of bean plants by P. syringae pv. syringae strain B728a, expression of the pseF gene increased 3 days after inoculation. Thus, the PseF protein, an ABC transporter, responsible for secretion of syringomycin and syringopeptin is required for full virulence.
|
4 |
Aminoglycosides and Syringomycin E as Fungicides Against Fusarium graminearum in Head Blight DiseaseKawasaki, Yukie 01 December 2008 (has links)
Fusarium graminearum is one of the most problematic phytopathogens in US agriculture. This fungus causes head blight, foot rot, and damping off on wheat and barley. The infection lowers the grain yield and causes contamination of the grain product with mycotoxins. Effective control measures are lacking, and new fungicides that kill F. graminearum but remain safe and economical to use are needed. Newly synthesized aminoglycosides (JL22, JL38, JL39, JL40, NEOF004, NEOF005), classic aminoglycosides (amikacin, gentamicin, kanamycin A, kanamycin B, neomycin, and ribostamycin), and a lipopeptide, syringomycin E (SRE), were studied to determine their antifungal potential to control F. graminearum. Aminoglycosides are protein synthesis inhibitors that mainly target bacteria, but a few were recently observed to kill fungi. They consist of an aminocyclitol ring bound with two or more amino sugars. Novel aminoglycosides were recently synthesized using novel glycodiversification synthetic schemes involving the replacement of the original amino sugars with unusual amino sugars. SRE is an antifungal lipodepsinonapeptide produced by Pseudomonas syringae pv. syringae. This bacterium is an opportunistic pathogen in a wide range of plant species and produces several fungicidal lipopeptides. SRE forms pores on fungal plasma membrane and causes ion fluxes. An enhancement of its antifungal activity is reported in the presence of rhamnolipid surfactants. The antifungal activities of various aminoglycosides, SRE, and a SRE-rhamnolipids mixture were determined against F. graminearum by measuring in vitro minimum inhibition concentrations (MICs) and in planta lesion area and chlorosis development using a leaf infection assay protocol. It was determined that using Tween® 20 at 0.2 % (v/v) concentration in the leaf infection assay promotes lesion development by F. graminearum with minimum phytotoxicity. In vitro, SRE, SYRA, and synthetic aminoglycoside JL38 showed the best antifungal activities. With the in planta assay, all three antifungal agents prevented infection by F. graminearum. However, inconsistent phytotoxicities were observed with SRE and SYRA that were influenced by the Tween® 20 surfactant included in the leaf infection assay. How Tween® 20 induces these phytotoxic inconsistencies is not known.
|
Page generated in 0.0554 seconds